Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03861494 · ClinicalTrials.gov registry record · NA
REcurrent Stroke Prevention Through Personalized Education by Clinical Trainers (RESPPECT Trial)
A NA study of Ischemic Stroke, sponsored by Washington Regional Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT03861494: Completed NA study of Ischemic Stroke, sponsored by Washington Regional Medical Center.
NCT03861494 is a NA study of Ischemic Stroke that has completed, run by Washington Regional Medical Center. The registered enrollment target is 21 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03861494, a NA study of Ischemic Stroke, has completed, sponsored by Washington Regional Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
This a single blind randomized control study comparing standard of care for nursing hospital discharge education versus same with an additional experimental enhanced educational intervention. It is planned that 300 patients will be enrolled in the study. There are two initial groups: the enhanced stroke education vs usual stroke education.
Primary Outcome
2.1.1 We will measure participant retention of in-hospital stroke education using a Stroke Knowledge Questionnaire. The questionnaire consists of 17 items. Scores range from 1-17. The questionnaire is based on the American Heart Association Stroke Knowledge Questionnaire. The questionnaire is administered during incident hospitalization for stroke (baseline score) and repeated at the 1 month post discharge appointment. The baseline score is subtracted from the 1 month appointment score and the r
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Stroke Education
- BEHAVIORAL Usual Stroke Education
Study Locations (1)
Arkansas
- Washington Regional Medical Center - Fayetteville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-05-06 |
| Est. Completion | 2021-09-14 |
| Phase | NA |
What the finished NCT03861494 record still lists
NCT03861494 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Stroke Education is the first listed.
NCT03861494 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT03861494 about?
NCT03861494 is a clinical study titled "REcurrent Stroke Prevention Through Personalized Education by Clinical Trainers (RESPPECT Trial)". This a single blind randomized control study comparing standard of care for nursing hospital discharge education versus same with an additional experimental enhanced educational intervention. It is planned that 300 patients will be enrolled in the study. There are two initial groups: the enhanced st...
What is the current status of trial NCT03861494?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2019-05-06. Estimated completion is 2021-09-14.
What conditions does trial NCT03861494 study?
This clinical trial studies the following conditions: Ischemic Stroke.
What interventions are being tested in trial NCT03861494?
The interventions under investigation include: Enhanced Stroke Education (BEHAVIORAL), Usual Stroke Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT03861494?
This trial is sponsored by Washington Regional Medical Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03861494 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03861494's enrollment target sits among peer trials
21 54th of 66 higher than 13 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
StrokeNet Thrombectomy Endovascular Platform
RECRUITING · NA
-
Virtual Reality Based Rehabilitation After Ischemic Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI